rs114078313

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001364171.2(ODAD1):​c.730G>A​(p.Glu244Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000753 in 1,614,100 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0042 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00040 ( 5 hom. )

Consequence

ODAD1
NM_001364171.2 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.219

Publications

2 publications found
Variant links:
Genes affected
ODAD1 (HGNC:26560): (outer dynein arm docking complex subunit 1) This gene encodes a coiled-coil domain-containing protein that is a component of the outer dynein arm docking complex in cilia cells. Mutations in this gene may cause primary ciliary dyskinesia 20. [provided by RefSeq, May 2013]
ODAD1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 20
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0044665635).
BP6
Variant 19-48304076-C-T is Benign according to our data. Variant chr19-48304076-C-T is described in ClinVar as Benign. ClinVar VariationId is 241879.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00415 (633/152352) while in subpopulation AFR AF = 0.0145 (604/41594). AF 95% confidence interval is 0.0136. There are 4 homozygotes in GnomAd4. There are 323 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ODAD1NM_001364171.2 linkc.730G>A p.Glu244Lys missense_variant Exon 9 of 16 ENST00000674294.1 NP_001351100.1
ODAD1NM_144577.4 linkc.619G>A p.Glu207Lys missense_variant Exon 7 of 14 NP_653178.3 Q96M63-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ODAD1ENST00000674294.1 linkc.730G>A p.Glu244Lys missense_variant Exon 9 of 16 NM_001364171.2 ENSP00000501363.1 A0A6I8PTZ2

Frequencies

GnomAD3 genomes
AF:
0.00415
AC:
632
AN:
152234
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00108
AC:
271
AN:
251296
AF XY:
0.000766
show subpopulations
Gnomad AFR exome
AF:
0.0146
Gnomad AMR exome
AF:
0.000810
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.000399
AC:
583
AN:
1461748
Hom.:
5
Cov.:
34
AF XY:
0.000323
AC XY:
235
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.0142
AC:
477
AN:
33480
American (AMR)
AF:
0.000917
AC:
41
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53362
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1111940
Other (OTH)
AF:
0.000927
AC:
56
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
33
65
98
130
163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00415
AC:
633
AN:
152352
Hom.:
4
Cov.:
33
AF XY:
0.00434
AC XY:
323
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.0145
AC:
604
AN:
41594
American (AMR)
AF:
0.00124
AC:
19
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68034
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
29
58
87
116
145
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00152
Hom.:
1
Bravo
AF:
0.00456
ESP6500AA
AF:
0.0145
AC:
64
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00124
AC:
151
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Oct 28, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jan 18, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
12
DANN
Benign
0.97
DEOGEN2
Benign
0.0037
T
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.98
FATHMM_MKL
Benign
0.024
N
LIST_S2
Benign
0.57
T
MetaRNN
Benign
0.0045
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.5
L
PhyloP100
0.22
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.064
Sift
Benign
0.28
T
Sift4G
Benign
0.10
T
Polyphen
0.95
P
Vest4
0.23
MVP
0.27
MPC
0.33
ClinPred
0.0033
T
GERP RS
-0.42
Varity_R
0.077
gMVP
0.23
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114078313; hg19: chr19-48807333; API